Similarly, the gut microbiota member Fusobacterium nucleatum and its product succinic acid confer resistance to anti-PD-1 mAb by inhibiting the cGAS-interferon-β pathway, thereby impairing CD8+ T cell-mediated anti-tumor immunity in the CRC. The gene discussed is CD8A; the disease is neoplasm.